U.S. Senate to vote this spring on lowering insulin prices - Senator Schumer

[March 23, 2022]  WASHINGTON (Reuters) - U.S. Senate Majority Leader Chuck Schumer said on Tuesday he intends to hold votes this spring on a bill that would cap the cost of insulin, a life-sustaining diabetes drug.

The legislation would place a $35 monthly cap on what patients pay for insulin, Schumer said, and would be paired with another emerging bipartisan plan to drive down the price "in a more comprehensive way, including having the uninsured protected," Schumer told reporters.

U.S. Senate Majority Leader Chuck Schumer (D-NY) faces reporters following the Senate Democrats weekly policy lunch at the U.S. Capitol in Washington, U.S., March 8, 2022. REUTERS/Evelyn Hockstein/File Photo

The Democratic leader added that he is working to place the legislation on the floor of the full Senate following a recess that ends in late April.

(Reporting by Richard Cowan; Writing by Katharine Jackson; Editing by Doina Chiacu and Jonathan Oatis)

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.